http://ift.tt/2qwwuHO
Glenmark will be able to launch Nebivolol tablets in September 2021 as per the prior settlement agreement with Forest. According to IMS Health sales data for the 12 month period ending March 2017, the Bystolic tablets have annual sales of approximately USD 1 billion.
May 29, 2017 at 01:14PM
from
No comments:
Post a Comment